Memogain, also known as benzgalantamine, is a cholinesterase inhibitor within the benzofuroazepine class, currently investigated for its potential to enhance acetylcholine activity in the brain for the… Read more






Memogain, also known as benzgalantamine, is a cholinesterase inhibitor within the benzofuroazepine class, currently investigated for its potential to enhance acetylcholine activity in the brain for the treatment of Alzheimer's disease. Analytical laboratories require high-quality Memogain reference standards and related compounds to support rigorous drug development processes. This collection includes the active pharmaceutical ingredient, alongside specific impurities like Memogain Impurity 1 Iodide, which are essential for comprehensive impurity profiling and quality control assessments required for regulatory submissions. Furthermore, stable isotope labelled compounds such as Memogain-d6 and O-methyl-d3 derivatives serve as critical internal standards in mass spectrometry-based bioanalysis. These materials are vital for method validation, ensuring accurate quantification and characterization of the drug substance and its metabolic products throughout the analytical lifecycle.